Profile
Steve Blumenthal is the founder of Synchron Corp.
which was founded in 1980.
He is currently the Chairman of Cynvec LLC.
He previously worked as a Principal at Bache & Co., Inc. Mr. Blumenthal received an undergraduate degree from the State University of New York at Buffalo.
Steve Blumenthal active positions
| Companies | Position | Start |
|---|---|---|
Cynvec LLC
 Cynvec LLC Pharmaceuticals: MajorHealth Technology Cynvec LLC develops oncolytic therapeutics for the treatment of cancer. It offers cancer treatment platform to activate the body’s own immune system to safely attack tumors and prevent or slow cancer recurrence. The firm develops CYN-101, a bioengineered Sindbis viral vector vaccine expressing the NY-ESO-1 tumor associated antigen for the treatment of late-stage ovarian cancer; and an immunotherapeutic vaccine for multiple possible cancer targets. The company was founded in 2004 and is headquartered in New York, NY. | Chairman | 2009-09-16 |
Former positions of Steve Blumenthal
| Companies | Position | End |
|---|---|---|
| Synchron Corp. | Founder | - |
Bache & Co., Inc.
 Bache & Co., Inc. Investment Banks/BrokersFinance Bache & Co., Inc. provides stock brokerage and investment banking services. The private company is based in Buffalo, NY. | Corporate Officer/Principal | - |
Training of Steve Blumenthal
| State University of New York at Buffalo | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Cynvec LLC
Cynvec LLC Pharmaceuticals: MajorHealth Technology Cynvec LLC develops oncolytic therapeutics for the treatment of cancer. It offers cancer treatment platform to activate the body’s own immune system to safely attack tumors and prevent or slow cancer recurrence. The firm develops CYN-101, a bioengineered Sindbis viral vector vaccine expressing the NY-ESO-1 tumor associated antigen for the treatment of late-stage ovarian cancer; and an immunotherapeutic vaccine for multiple possible cancer targets. The company was founded in 2004 and is headquartered in New York, NY. | Health Technology |
Bache & Co., Inc.
Bache & Co., Inc. Investment Banks/BrokersFinance Bache & Co., Inc. provides stock brokerage and investment banking services. The private company is based in Buffalo, NY. | Finance |
| Synchron Corp. |
- Stock Market
- Insiders
- Steve Blumenthal
